{"name":"Allife Medical Science and Technology Co., Ltd.","slug":"allife-medical-science-and-technology-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Induction of neural stem cells","genericName":"Induction of neural stem cells","slug":"induction-of-neural-stem-cells","indication":"Other","status":"phase_1"},{"name":"Anti-CD19 iCAR NK Cells","genericName":"Anti-CD19 iCAR NK Cells","slug":"anti-cd19-icar-nk-cells","indication":"Relapsed or refractory B-cell malignancies","status":"phase_1"},{"name":"Anti-CD22 CAR NK Cells","genericName":"Anti-CD22 CAR NK Cells","slug":"anti-cd22-car-nk-cells","indication":"B-cell malignancies","status":"phase_1"}]}],"pipeline":[{"name":"Induction of neural stem cells","genericName":"Induction of neural stem cells","slug":"induction-of-neural-stem-cells","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Anti-CD19 iCAR NK Cells","genericName":"Anti-CD19 iCAR NK Cells","slug":"anti-cd19-icar-nk-cells","phase":"phase_1","mechanism":"CD19-targeting chimeric antigen receptor (CAR) T cells","indications":["Relapsed or refractory B-cell malignancies"],"catalyst":""},{"name":"Anti-CD22 CAR NK Cells","genericName":"Anti-CD22 CAR NK Cells","slug":"anti-cd22-car-nk-cells","phase":"phase_1","mechanism":"Targeting CD22 on B cells","indications":["B-cell malignancies"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxOU3hfa0JPVU9zTXZWc1A0WkRUYVhLZlB3c1RPc1FxVU1mSFBlN0lQT0tOMHlvbXJwRlZMbFhxdV9zTkxfWXBkUFdGcWZaQkFRMHpNMWFvUGpTVjlHZzluYXp4QXI5TlJrT0NXR2JwMGFrd3hZeFdyUzVuR0NuZnVuSkEzdjRRUEFqWXhPUjhsRXBEeUFIZl9jLVc1VVoyaHRmWFRVTWw0S3pFOV9xMlYzU2RpR2ZEV1dieWpjRTd4eElFY2V6UkdhdWNOd0NUUXk1Um95SjhVNHRRRUxXNGtzc2d4a2NkcjN3YmlUWEZCWTlkc2U4YlNyMW50XzFzdw?oc=5","date":"2026-02-16","type":"trial","source":"Investing News Network","summary":"IPSC-derived NK Cells Clinical Trial Pipeline Gains Momentum: 12+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Investing News Network","headline":"IPSC-derived NK Cells Clinical Trial Pipeline Gains Momentum: 12+ Companies Lead the Charge in Pioneering New Treatments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQSDBXZ243SnRELU9tTG5VZTBBaUFIQkVwVmJEYW42OGc5emVxOWVhSGlZcng5U1RDZE5IWUM5YUdYRE1VSDBpVFZxTW5iNUF0X29DSUlDa3RBaHpKRmhwODNuU1hlRmEyQzNDLU9VUlVYN29vb3dTZFl1T21FU2FWNXpGZklzS2hZQXNoV21KczXSAZYBQVVfeXFMTmdVSG5xdU5Qa2JKdFpoQWYyaHhkUkxfM1FUdmljWjc5Z2VZYkxxRzhsa0VmZWZXc2h1UWY4MFFibXlwbXplT0VBS2dITk5ya1oxVlRwN3JJUF9fOFkwQlZ5eHB1NmNwRWZQV0NvMVlmSDZka3laZlZTMjNaN1FXdWxiU0hUSC1XckpWb09qRGNVSDI3UXdR?oc=5","date":"2026-01-17","type":"pipeline","source":"BioInformant","summary":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide - BioInformant","headline":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxOLTNGclp3R1k1Ql95djVkdTRCRG1mbmlmSDhFTm52MlJGZjdaNG9qU1VfbWxyUUVoOWs3aUJvUUY2M3o4bEtfUExtVXNOY1F0MUU3MzRWbFRSYmZMb0V2eEJuUnNTU1cxQUVFbXZieW1TQmxXRWxuUDRtZlM2allWeUpNQlVvN0gyNHNaSE9CTjQ0TE84ZTJJT0tlSlQtX0FCQWNqMXdhMElMa1lRdDgtZDRRNU84U1otT2ZCbXdEekttb3FKSFNZbnIxRndueUw4S0d4OTR5V3BpNkV0dTNTRzVMM2oxVGxrd1p3TFZCZmNpdXIyZGJkWm1xOW83aDM0UFV2WUM3cTdWOHVrUDg2VHJqcC1YNmxmbWl4VmlhNjlKYkZHMXc?oc=5","date":"2024-11-11","type":"trial","source":"PR Newswire","summary":"NK Cell Therapy Clinical Trial Pipeline Appears Robust With 140+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - PR Newswire","headline":"NK Cell Therapy Clinical Trial Pipeline Appears Robust With 140+ Key Pharma Companies Actively Working in the Therapeuti","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQRGowd0t1WHN4X2p5MmdfWU1ET01VdDBRdkVCZkFjTmxTeklFbTN0bWZYMTlUeVhYSXUxTnRGeFdnOV9VZUtkSnVCRjJ6RTlJWHpiakpwVjV5MGJvWGhBWXc5V292dUZFNUxlMjZ6SF9BZmNTOEllQkZvTlYyOFJwMmdpSFhFR2RKN3RaV2VMcno4TTRMS09WYkQwUng?oc=5","date":"2023-07-26","type":"pipeline","source":"CRISPR Medicine News","summary":"Clinical Roundup: Gene-Edited Therapies for Beta Thalassemia - CRISPR Medicine News","headline":"Clinical Roundup: Gene-Edited Therapies for Beta Thalassemia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE02d1QweHFSa1ZWbmNoaTZVdnZoSFdPMEdMYTZOZ0laOWY1cTlLUXh1aGdHOTh0a2tZU0lWMU9udkMwYWJQYVduaG9iLUxYXzNHR08wZXJKZjB3WG82d0Z3?oc=5","date":"2021-07-15","type":"pipeline","source":"Cure Parkinson's","summary":"The Bluerockers have started - Cure Parkinson's","headline":"The Bluerockers have started - Cure Parkinson's","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE01c2dJNXdJVGJNd2MtN2Z2TkVkT1k5WGNVTmVIbVdsV29KLVc2MlgwMWxGSWVJUm9Ra2pXdm5pRTNTNW1waWdsWWhIckZqOWo3Yk9qODNmQjlFZllfOXZWVnhLY3NSZm5HWXhaWVJaQkVrT2lQX3NZTA?oc=5","date":"2020-11-17","type":"trial","source":"CRISPR Medicine News","summary":"CRISPR-Cas Clinical Trial Update - CRISPR Medicine News","headline":"CRISPR-Cas Clinical Trial Update","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_1":3},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}